Guan-tian Lang

Key Laboratory Of Breast Cancer In Shanghai
Shanghai, 200032, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Novel Insights into the Enigmatic Genetics of Male Breast Cancer in China.

Novel Insights into the Enigmatic Genetics of Male Breast Cancer in China.

Journal: Pathophysiology : the official journal of the International Society for Pathophysiology

Published: November 30, 2025

Large-scale genomic sequencing reveals adaptive opportunity of targeting mutated-PI3Kα in early and advanced HER2-positive breast cancer.

Large-scale genomic sequencing reveals adaptive opportunity of targeting mutated-PI3Kα in early and advanced HER2-positive breast cancer.

Journal: Clinical and translational medicine

Published: April 18, 2021

A predictor of pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancer patients with the DNA repair genes.

A predictor of pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancer patients with the DNA repair genes.

Journal: Annals of translational medicine

Published: March 12, 2021

Multiple cancer susceptible genes sequencing in BRCA-negative breast cancer with high hereditary risk.

Multiple cancer susceptible genes sequencing in BRCA-negative breast cancer with high hereditary risk.

Journal: Annals of translational medicine

Published: December 14, 2020

Characterization of the genomic landscape and actionable mutations in Chinese breast cancers by clinical sequencing.

Characterization of the genomic landscape and actionable mutations in Chinese breast cancers by clinical sequencing.

Journal: Nature communications

Published: April 18, 2020

Dissecting the heterogeneity of the alternative polyadenylation profiles in triple-negative breast cancers.

Dissecting the heterogeneity of the alternative polyadenylation profiles in triple-negative breast cancers.

Journal: Theranostics

Published: October 06, 2019

Concordance of Hormone Receptor Status and BRCA1/2 Mutation Among Women With Synchronous Bilateral Breast Cancer.

Concordance of Hormone Receptor Status and BRCA1/2 Mutation Among Women With Synchronous Bilateral Breast Cancer.

Journal: Frontiers in oncology

Published: July 06, 2019

Interaction between glutathione S-transferase M1-null/present polymorphism and adjuvant chemotherapy influences the survival of breast cancer.

Interaction between glutathione S-transferase M1-null/present polymorphism and adjuvant chemotherapy influences the survival of breast cancer.

Journal: Cancer medicine

Published: December 13, 2017

The spectrum of BRCA mutations and characteristics of BRCA-associated breast cancers in China: Screening of 2,991 patients and 1,043 controls by next-generation sequencing.

The spectrum of BRCA mutations and characteristics of BRCA-associated breast cancers in China: Screening of 2,991 patients and 1,043 controls by next-generation sequencing.

Journal: International journal of cancer

Published: November 11, 2016

Androgen receptor expression predicts different clinical outcomes for breast cancer patients stratified by hormone receptor status.

Androgen receptor expression predicts different clinical outcomes for breast cancer patients stratified by hormone receptor status.

Journal: Oncotarget

Published: February 26, 2016

Showing 1-10 of 10

Last Updated: 09/26/2026